What is the current valuation of the UK medical device market?

The UK medical device market was valued at 37.74 USD Billion in 2024. Read More

What is the projected market size for the market by 2035?

The market is projected to reach 74.45 USD Billion by 2035. Read More

What is the expected CAGR for the UK medical device market during the forecast period?

The expected CAGR for the UK medical device market from 2025 to 2035 is 6.37%. Read More

Which companies are considered key players in the market?

Key players include Medtronic (GB), Johnson & Johnson (GB), Siemens Healthineers (DE), and GE Healthcare (GB), among others. Read More

What are the main segments of the market by application?

The main segments by application include Diagnostic Devices, Therapeutic Devices, Monitoring Devices, Surgical Instruments, and Consumables. Read More

How do the revenues of diagnostic devices compare to therapeutic devices in the UK market?

Diagnostic Devices generated revenues of 8.0 to 15.0 USD Billion, whereas Therapeutic Devices ranged from 10.0 to 20.0 USD Billion. Read More

What is the revenue range for surgical instruments in the UK medical device market?

Surgical Instruments generated revenues between 6.0 and 12.0 USD Billion. Read More

Which end-use segments are prominent in the UK medical device market?

Prominent end-use segments include Hospitals, Clinics, Home Care, and Ambulatory Surgical Centers. Read More

What is the revenue range for imaging devices in the market?

Imaging Devices generated revenues between 8.0 and 15.0 USD Billion. Read More

How are the regulatory classifications of devices structured in the UK market?

Regulatory classifications include Class I, Class II, Class III, Combination Devices, and Custom Devices, with Class II Devices generating 12.23 to 24.45 USD Billion. Read More

UK Medical Device Market

ID: MRFR/MED/42603-HCR

200 Pages

Rahul Gotadki

Last Updated: April 06, 2026

UK Medical Device Market Research Report By Device Type Outlook (Drug Delivery System, Diagnostic Devices, Invasive Devices, Respiratory Therapeutic Devices, Electronic Medical Device, Others), By Application Outlook (Cardiovascular Diseases, Diagnostic Imaging, Orthopedics, Oncology, Ophthalmology, General Surgery, Respiratory, Dental, Ear, Nose, and Throat (ENT), Neurology, Nephrology Urology, Others) and By End User Outlook (Hospitals Clinics, Ambulatory Surgical Centers, Homecare Settings, Others) - Growth & Industry Forecast 2025 To 2035

Summary Table of Contents Segmentation Download PDF

SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
1. 1.1 EXECUTIVE SUMMARY | |
  1. 1.1.1 Market Overview | |
  2. 1.1.2 Key Findings | |
  3. 1.1.3 Market Segmentation | |
  4. 1.1.4 Competitive Landscape | |
  5. 1.1.5 Challenges and Opportunities | |
  6. 1.1.6 Future Outlook 2
SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
1. 2.1 MARKET INTRODUCTION | |
  1. 2.1.1 Definition | |
  2. 2.1.2 Scope of the study | | |
    1. 2.1.2.1 Research Objective | | |
    2. 2.1.2.2 Assumption | | |
    3. 2.1.2.3 Limitations |
2. 2.2 RESEARCH METHODOLOGY | |
  1. 2.2.1 Overview | |
  2. 2.2.2 Data Mining | |
  3. 2.2.3 Secondary Research | |
  4. 2.2.4 Primary Research | | |
    1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
    2. 2.2.4.2 Breakdown of Primary Respondents | |
  5. 2.2.5 Forecasting Model | |
  6. 2.2.6 Market Size Estimation | | |
    1. 2.2.6.1 Bottom-Up Approach | | |
    2. 2.2.6.2 Top-Down Approach | |
  7. 2.2.7 Data Triangulation | |
  8. 2.2.8 Validation 3
SECTION III: QUALITATIVE ANALYSIS |
1. 3.1 MARKET DYNAMICS | |
  1. 3.1.1 Overview | |
  2. 3.1.2 Drivers | |
  3. 3.1.3 Restraints | |
  4. 3.1.4 Opportunities |
2. 3.2 MARKET FACTOR ANALYSIS | |
  1. 3.2.1 Value chain Analysis | |
  2. 3.2.2 Porter's Five Forces Analysis | | |
    1. 3.2.2.1 Bargaining Power of Suppliers | | |
    2. 3.2.2.2 Bargaining Power of Buyers | | |
    3. 3.2.2.3 Threat of New Entrants | | |
    4. 3.2.2.4 Threat of Substitutes | | |
    5. 3.2.2.5 Intensity of Rivalry | |
  3. 3.2.3 COVID-19 Impact Analysis | | |
    1. 3.2.3.1 Market Impact Analysis | | |
    2. 3.2.3.2 Regional Impact | | |
    3. 3.2.3.3 Opportunity and Threat Analysis 4
SECTION IV: QUANTITATIVE ANALYSIS |
1. 4.1 Healthcare, BY Application (USD Billion) | |
  1. 4.1.1 Diagnostic Devices | |
  2. 4.1.2 Therapeutic Devices | |
  3. 4.1.3 Monitoring Devices | |
  4. 4.1.4 Surgical Instruments | |
  5. 4.1.5 Consumables |
2. 4.2 Healthcare, BY End Use (USD Billion) | |
  1. 4.2.1 Hospitals | |
  2. 4.2.2 Clinics | |
  3. 4.2.3 Home Care | |
  4. 4.2.4 Ambulatory Surgical Centers | |
  5. 4.2.5 Diagnostic Laboratories |
3. 4.3 Healthcare, BY Device Type (USD Billion) | |
  1. 4.3.1 Imaging Devices | |
  2. 4.3.2 Surgical Devices | |
  3. 4.3.3 Patient Monitoring Devices | |
  4. 4.3.4 In Vitro Diagnostic Devices | |
  5. 4.3.5 Dental Devices |
4. 4.4 Healthcare, BY Technology (USD Billion) | |
  1. 4.4.1 Electromechanical Devices | |
  2. 4.4.2 Biotechnology Devices | |
  3. 4.4.3 Nanotechnology Devices | |
  4. 4.4.4 Software-based Devices | |
  5. 4.4.5 Wearable Devices |
5. 4.5 Healthcare, BY Regulatory Classification (USD Billion) | |
  1. 4.5.1 Class I Devices | |
  2. 4.5.2 Class II Devices | |
  3. 4.5.3 Class III Devices | |
  4. 4.5.4 Combination Devices | |
  5. 4.5.5 Custom Devices 5
SECTION V: COMPETITIVE ANALYSIS |
1. 5.1 Competitive Landscape | |
  1. 5.1.1 Overview | |
  2. 5.1.2 Competitive Analysis | |
  3. 5.1.3 Market share Analysis | |
  4. 5.1.4 Major Growth Strategy in the Healthcare | |
  5. 5.1.5 Competitive Benchmarking | |
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare | |
  7. 5.1.7 Key developments and growth strategies | | |
    1. 5.1.7.1 New Product Launch/Service Deployment | | |
    2. 5.1.7.2 Merger & Acquisitions | | |
    3. 5.1.7.3 Joint Ventures | |
  8. 5.1.8 Major Players Financial Matrix | | |
    1. 5.1.8.1 Sales and Operating Income | | |
    2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
2. 5.2 Company Profiles | |
  1. 5.2.1 Medtronic (GB) | | |
    1. 5.2.1.1 Financial Overview | | |
    2. 5.2.1.2 Products Offered | | |
    3. 5.2.1.3 Key Developments | | |
    4. 5.2.1.4 SWOT Analysis | | |
    5. 5.2.1.5 Key Strategies | |
  2. 5.2.2 Johnson & Johnson (GB) | | |
    1. 5.2.2.1 Financial Overview | | |
    2. 5.2.2.2 Products Offered | | |
    3. 5.2.2.3 Key Developments | | |
    4. 5.2.2.4 SWOT Analysis | | |
    5. 5.2.2.5 Key Strategies | |
  3. 5.2.3 Siemens Healthineers (DE) | | |
    1. 5.2.3.1 Financial Overview | | |
    2. 5.2.3.2 Products Offered | | |
    3. 5.2.3.3 Key Developments | | |
    4. 5.2.3.4 SWOT Analysis | | |
    5. 5.2.3.5 Key Strategies | |
  4. 5.2.4 Philips (NL) | | |
    1. 5.2.4.1 Financial Overview | | |
    2. 5.2.4.2 Products Offered | | |
    3. 5.2.4.3 Key Developments | | |
    4. 5.2.4.4 SWOT Analysis | | |
    5. 5.2.4.5 Key Strategies | |
  5. 5.2.5 GE Healthcare (GB) | | |
    1. 5.2.5.1 Financial Overview | | |
    2. 5.2.5.2 Products Offered | | |
    3. 5.2.5.3 Key Developments | | |
    4. 5.2.5.4 SWOT Analysis | | |
    5. 5.2.5.5 Key Strategies | |
  6. 5.2.6 Baxter International (US) | | |
    1. 5.2.6.1 Financial Overview | | |
    2. 5.2.6.2 Products Offered | | |
    3. 5.2.6.3 Key Developments | | |
    4. 5.2.6.4 SWOT Analysis | | |
    5. 5.2.6.5 Key Strategies | |
  7. 5.2.7 Stryker (US) | | |
    1. 5.2.7.1 Financial Overview | | |
    2. 5.2.7.2 Products Offered | | |
    3. 5.2.7.3 Key Developments | | |
    4. 5.2.7.4 SWOT Analysis | | |
    5. 5.2.7.5 Key Strategies | |
  8. 5.2.8 Boston Scientific (US) | | |
    1. 5.2.8.1 Financial Overview | | |
    2. 5.2.8.2 Products Offered | | |
    3. 5.2.8.3 Key Developments | | |
    4. 5.2.8.4 SWOT Analysis | | |
    5. 5.2.8.5 Key Strategies | |
  9. 5.2.9 Abbott Laboratories (US) | | |
    1. 5.2.9.1 Financial Overview | | |
    2. 5.2.9.2 Products Offered | | |
    3. 5.2.9.3 Key Developments | | |
    4. 5.2.9.4 SWOT Analysis | | |
    5. 5.2.9.5 Key Strategies |
3. 5.3 Appendix | |
  1. 5.3.1 References | |
  2. 5.3.2 Related Reports 6 LIST OF FIGURES |
4. 6.1 MARKET SYNOPSIS |
5. 6.2 UK MARKET ANALYSIS BY APPLICATION |
6. 6.3 UK MARKET ANALYSIS BY END USE |
7. 6.4 UK MARKET ANALYSIS BY DEVICE TYPE |
8. 6.5 UK MARKET ANALYSIS BY TECHNOLOGY |
9. 6.6 UK MARKET ANALYSIS BY REGULATORY CLASSIFICATION |
10. 6.7 KEY BUYING CRITERIA OF HEALTHCARE |
11. 6.8 RESEARCH PROCESS OF MRFR |
12. 6.9 DRO ANALYSIS OF HEALTHCARE |
13. 6.10 DRIVERS IMPACT ANALYSIS: HEALTHCARE |
14. 6.11 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE |
15. 6.12 SUPPLY / VALUE CHAIN: HEALTHCARE |
16. 6.13 HEALTHCARE, BY APPLICATION, 2024 (% SHARE) |
17. 6.14 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion) |
18. 6.15 HEALTHCARE, BY END USE, 2024 (% SHARE) |
19. 6.16 HEALTHCARE, BY END USE, 2024 TO 2035 (USD Billion) |
20. 6.17 HEALTHCARE, BY DEVICE TYPE, 2024 (% SHARE) |
21. 6.18 HEALTHCARE, BY DEVICE TYPE, 2024 TO 2035 (USD Billion) |
22. 6.19 HEALTHCARE, BY TECHNOLOGY, 2024 (% SHARE) |
23. 6.20 HEALTHCARE, BY TECHNOLOGY, 2024 TO 2035 (USD Billion) |
24. 6.21 HEALTHCARE, BY REGULATORY CLASSIFICATION, 2024 (% SHARE) |
25. 6.22 HEALTHCARE, BY REGULATORY CLASSIFICATION, 2024 TO 2035 (USD Billion) |
26. 6.23 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
27. 7.1 LIST OF ASSUMPTIONS | |
  1. 7.1.1 |
28. 7.2 UK MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.2.1 BY APPLICATION, 2026-2035 (USD Billion) | |
  2. 7.2.2 BY END USE, 2026-2035 (USD Billion) | |
  3. 7.2.3 BY DEVICE TYPE, 2026-2035 (USD Billion) | |
  4. 7.2.4 BY TECHNOLOGY, 2026-2035 (USD Billion) | |
  5. 7.2.5 BY REGULATORY CLASSIFICATION, 2026-2035 (USD Billion) |
29. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
  1. 7.3.1 |
30. 7.4 ACQUISITION/PARTNERSHIP | |

Certified Researchers

Customize Report

UK Healthcare Market Segmentation

Healthcare By Application (USD Billion, 2026-2035)

Diagnostic Devices
Therapeutic Devices
Monitoring Devices
Surgical Instruments
Consumables

Healthcare By End Use (USD Billion, 2026-2035)

Hospitals
Clinics
Home Care
Ambulatory Surgical Centers
Diagnostic Laboratories

Healthcare By Device Type (USD Billion, 2026-2035)

Imaging Devices
Surgical Devices
Patient Monitoring Devices
In Vitro Diagnostic Devices
Dental Devices

Healthcare By Technology (USD Billion, 2026-2035)

Electromechanical Devices
Biotechnology Devices
Nanotechnology Devices
Software-based Devices
Wearable Devices

Healthcare By Regulatory Classification (USD Billion, 2026-2035)

Class I Devices
Class II Devices
Class III Devices
Combination Devices
Custom Devices

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Features	License Type
Features	Single User	Multiuser License	Enterprise User
Price	$4,950	$5,950	$7,250
Maximum User Access Limit	1 User	Upto 10 Users	Unrestricted Access Throughout the Organization
Free Customization	✓	✓	✓
Direct Access to Analyst	✓	✓	✓
Deliverable Format	✓	✓	✓
Platform Access	✗	✗	✓
Discount on Next Purchase	10%	15%	15%
Printable Versions	✗	✗	✓